CTIS2024-513997-23-00招募中1 期
Evaluation of 68GaNOTA-Anti-HER2 VHH1 uptake in brain metastasis of cancer patients
niversitair Ziekenhuis Brussel0 个研究点目标入组 30 人开始时间: 2024年7月18日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Patients who have given informed consent, Age 18 years or older patients with brain metastasized cancer, with at least 1 brain lesion of at least 8 mm maximal diameter, as measured by CT or MRI, Patients with potentially HER2-positive cancer. Either a HER2 staining should have been done in standard of care, or sufficient tissue should be available for HER2-staining for study purpose
排除标准
- •Pregnant patients, Breast feeding patients, Patients with recent (< 1 week) gastrointestinal disorders with diarrhea as major symptom, Patients with any serious active infection, Patients who have any other life-threatening illness or organ system dysfunction, which in the opinion of the investigator would either compromise patient safety or interfere with the evaluation of the test radiopharmaceutical, Patients who cannot communicate reliably with the investigator, Patients at increased risk of death from a pre-existing concurrent illness
研究者
相似试验
招募中
2 期
Evaluation of 68GaNOTA-Anti-HER2 VHH1 uptake in brain metastasis of cancer patients2024-513997-23-00Universitair Ziekenhuis Brussel30
进行中（未招募）
1 期
Phase 2 Pilot study to evaluate the uptake of 68GaNOTA-anti-HER2 VHH1, a new tracer for positron emission tomografic imaging (PET/CT scan) of metastasis in cancer patients.prostate cancercolorectal cancerpancreatic cancerNon-small cell lung cancerBreast cancerEUCTR2016-002164-13-BEZ Brussel55
终止
2 期
Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer PatientsCarcinomaReceptor, ErbB-2NCT03331601Universitair Ziekenhuis Brussel7
招募中
2 期
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma PatientsMetastatic Breast CarcinomaLocally Advanced Breast CancerCancer of PancreasSolid Tumor With Intermediate or High HER2 ExpressionSalivary Gland CancerEndometrial CancerUterine CancerNon Small Cell Lung CancerBiliary Tract CancerUrothelial CarcinomaProstate CancerColorectal CancerGastric CancerCholangiocarcinomaNCT03924466Universitair Ziekenhuis Brussel55
进行中（未招募）
1 期
Phase 1/2 study of GH001 in depressioTreatment-resistant depressionEUCTR2018-004208-20-NLGh Research Limited16